REQUEST A DEMO
Total
USD $0.00
Search more companies

People Bio Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: People Bio Co.,Ltd. Profile Updated: August 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the manufacture and sale of medical supplies. The Company s main products include oligomerized beta-amyloid (OAss) test systems, and others. The Company's multimer detection system (MDS) is sandwich assay using capturing antibodies and epitope-overlapping detection antibodies for the detection of only oligomers or multimers from monomers in protein-misfolding diseases. The Company sells its products in domestic and overseas markets. The Company was established on September 9, 2002. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on October 19, 2020.

Headquarters
C Dong, Pdc, 242, Pangyo-Ro, Bundang-Gu
Seongnam; Gyeonggi;

Contact Details: Purchase the People Bio Co.,Ltd. report to view the information.

Website: http://www.peoplebio.net/kr/index.php

Basic Information
Total Employees:
Purchase the People Bio Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the People Bio Co.,Ltd. report to view the information.
Registered Capital:
Purchase the People Bio Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the People Bio Co.,Ltd. report to view the information.
Incorporation Date:
September 10, 2002
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
(주)뉴로바이오넷
Company Performance
Financial values in the chart are available after People Bio Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
671.61%
Total operating revenue
1132.33%
Operating profit (EBIT)
-127.7%
EBITDA
-115.05%
Net Profit (Loss) for the Period
-251.73%
Total assets
-46.29%
Total equity
3.41%
Operating Profit Margin (ROS)
924.15%
Net Profit Margin
466.01%
Return on Equity (ROE)
-62.41%
Debt to Equity Ratio
-59.31%
Quick Ratio
2.18%
Cash Ratio
-1.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?